“…Single-nucleotide variants (SNVs) in the core PCP genes CELSR1, FZD6, PRICKLE1, DVL2, VANGL1 and VANGL2 , and the PCP associated genes SEC24B, DACT1, FUZ and SCRIB [7,17–23] have been proposed as human NTD risk factors. In contrast to the association of mouse PCP gene mutations with craniorachischisis in homozygotes, most of the variants identified in human NTDs are heterozygous variants, and the PCP-mutation-associated NTD phenotypes vary widely ranging from the “open NTD” of craniorachischisis, myelomeningocele, and anencephaly, to the “closed NTD” of lipomyelomeningocele, lipomyelocele, and lipoma [2,7]. Unlike mouse models, variants in single genes may not explain the genetic mechanism underlying the development of human NTDs.…”